Your browser doesn't support javascript.
loading
Real-world Data of Nivolumab for Patients With Advanced Renal Cell Carcinoma in the Netherlands: An Analysis of Toxicity, Efficacy, and Predictive Markers.
Verhaart, Saskia Lisa; Abu-Ghanem, Yasmin; Mulder, Sasja F; Oosting, Sjoukje; Van Der Veldt, Astrid; Osanto, Susanne; Aarts, Maureen J B; Houtsma, Danny; Peters, Frank P J; Groenewegen, Gerard; Van Herpen, Carla M L; Pronk, Loes M; Tascilar, Metin; Hamberg, Paul; Los, Maartje; Vreugdenhil, Gerard; Polee, Marco; Ten Tije, Albert J; Haanen, John B A G; Bex, Axel; van den Eertwegh, Alfonsus J.
Affiliation
  • Verhaart SL; Specialist Centre for Kidney Cancer, Royal Free London NHS Foundation Trust, London, United Kingdom.
  • Abu-Ghanem Y; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Mulder SF; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Oosting S; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands.
  • Van Der Veldt A; Department of Medical Oncology, Erasmus Medical Center-Cancer Institute, Rotterdam, The Netherlands.
  • Osanto S; Department of Medical Oncology, Leids University Medical Center, Leiden, The Netherlands.
  • Aarts MJB; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Houtsma D; Department of Medical Oncology, HAGA Hospital, The Hague, The Netherlands.
  • Peters FPJ; Department of Medical Oncology, Zuyderland Hospital, Sittard - Geleen, The Netherlands.
  • Groenewegen G; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Van Herpen CML; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Pronk LM; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Tascilar M; Department of Medical Oncology, Isala Clinics, Zwolle, The Netherlands.
  • Hamberg P; Department of Medical Oncology, Franciscus Gasthuis and Vllietland, Rotterdam, The Netherlands.
  • Los M; Department of Medical Oncology, St. Antonius Hospital, Nieuwegein, The Netherlands.
  • Vreugdenhil G; Department of Medical Oncology, Máxima Medical Center, Eindhoven, The Netherlands.
  • Polee M; Department of Medical Oncology, Medical Center Leeuwarden, Leeuwarden, The Netherlands.
  • Ten Tije AJ; Department of Medical Oncology, Amphia Hospital, Breda, The Netherlands.
  • Haanen JBAG; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Bex A; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands; Division of Surgery and Interventional Science, University College London, London, United Kingdom; Department of Urology, The Netherlands Cancer Institute, Amsterdam, The
  • van den Eertwegh AJ; Specialist Centre for Kidney Cancer, Royal Free London NHS Foundation Trust, London, United Kingdom.
Clin Genitourin Cancer ; 19(3): 274.e1-274.e16, 2021 06.
Article in En | MEDLINE | ID: mdl-33317946

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Clin Genitourin Cancer Journal subject: NEOPLASIAS / UROLOGIA Year: 2021 Type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Clin Genitourin Cancer Journal subject: NEOPLASIAS / UROLOGIA Year: 2021 Type: Article Affiliation country: United kingdom